Ligand Announces Positive Preclinical Data on Selective Androgen Receptor Modulator LGD-3303 September 17, 2007
Ligand to Present at Thomas Weisel Partners and Bear Stearns Healthcare Conferences in September September 4, 2007
Ligand Pharmaceuticals Announces $353 Million Cash Dividend and Share Repurchase Authorization March 21, 2007